A Pilot Study to Determine Safety & Efficacy of Autologous Human Platelet Lysate (HPL) in Treatment of Acne Scarring

ACNE SCARRING Clinical Trial

Official title:
A Prospective, Multicentric, Open Label, Bio Interventional, Phase I, Phase II Pilot Study to Evaluate the Safety and Efficacy of Autologous Human Platelet Lysate (HPL) for Treatment of Acne Scarring

Status Completed

Clinical Trial Summary

This is a multicentre, open label, randomized, pilot study to evaluate safety and efficacy of Human Platelet Lysate (HPL) in subjects with Acne Scarring. The study is being conducted at 2 centers in India. The primary endpoint is change in the Global Acne scarring classification scores from screening to end of the study. The secondary endpoints are Photographic Assessment, Physicians assessment score and Patients self assessment score.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01644435
Study type	Interventional
Source	Kasiak Research Pvt. Ltd.
Contact
Status	Completed
Phase	Phase 1/Phase 2
Start date	May 2012
Completion date	October 2012

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00641420` - Safety and Efficacy of 1550nm Fractional Laser Treatment for Acne Scars in Fitzpatrick Type IV-VI Skin	N/A
Completed	`NCT00510055` - Treatment of Acne Scarring With a Novel Procedure Combination	N/A
Completed	`NCT05386732` - Safety and Efficacy of the 4MD Micro Needling Device in the Treatment of Acne Scars
Completed	`NCT02174393` - Microneedling Plus the Universal Peel For Acne Scarring	N/A